Tevogen Bio Holdings Inc. financial statements
Tevogen Bio Holdings Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | USD 0 | EODHD |
| Net income | −USD 26.28M | EODHD |
| Cash and equivalents | USD 552.37K | EODHD |
| Total debt | USD 3.1M | EODHD |
Tevogen Bio Holdings Inc. financials on 6ix · Tevogen Bio Holdings Inc. on 6ix